T1	Outcomes 618 658	incidence of in-breast recurrence (IBR).
T2	Outcomes 698 725	cumulative incidence of IBR
T3	Outcomes 806 820	no differences
T4	Outcomes 833 884	overall survival and distant disease-free survival.
T5	Outcomes 1035 1070	risk of distant-disease recurrence.
